Synkoloid ARTRA — Asbestos-Containing Joint Compound: Manufacturer Reference

Company History

Synkoloid ARTRA operated as a manufacturer of specialty construction products in the United States, producing finishing materials used extensively across the American construction industry during the post-World War II building boom. The company’s products were distributed into the professional drywall and plastering trades as well as the consumer home-improvement market, placing them on residential, commercial, and industrial jobsites throughout the country.

The precise founding date of Synkoloid ARTRA has not been independently confirmed in available public records, though the company’s products appear in asbestos litigation records spanning decades of active use during the mid-to-late twentieth century. Like many specialty building product manufacturers of the era, Synkoloid ARTRA operated during a period when asbestos was a standard additive in joint compounds, valued by manufacturers for its ability to improve workability, reduce cracking, and add tensile strength to finishing materials. Regulatory pressure, evolving industry standards, and mounting health concerns led most joint compound manufacturers to reformulate or discontinue asbestos-containing products by the early 1980s, and available records indicate Synkoloid ARTRA ceased asbestos use at approximately that time.

Asbestos-Containing Products

According to asbestos litigation records, Synkoloid ARTRA manufactured joint compound products that plaintiffs alleged contained asbestos as a functional ingredient. Joint compounds — also known as drywall mud or finishing compound — were applied by workers and homeowners to cover seams between drywall panels, tape joints, fill fastener depressions, and create smooth finished wall surfaces before painting.

Court filings document that asbestos-containing joint compounds produced during this era commonly incorporated chrysotile asbestos and, in some formulations, other asbestos fiber types, at concentrations that varied by product line and manufacturing period. Plaintiffs alleged that Synkoloid ARTRA’s joint compound formulations during the relevant period fell within this standard industry practice of asbestos incorporation.

Specific branded product names associated with Synkoloid ARTRA have not been independently confirmed in all available records. Researchers, attorneys, and exposed workers seeking to identify specific product formulations are encouraged to consult historical product safety data sheets, industrial hygiene records, archived trade literature, and deposition testimony from asbestos litigation proceedings in which Synkoloid ARTRA products have been identified.

The physical characteristics of joint compound created specific and well-documented hazards. The material was sold in both dry powder form and pre-mixed wet formulations. Dry powder products, when measured, mixed with water, or poured, generated substantial airborne dust. Pre-mixed compounds, once applied and allowed to cure, were sanded to achieve smooth surfaces — a process that consistently generated fine airborne particulate. Both processes are documented in occupational health literature as capable of releasing respirable asbestos fibers when the underlying product contained asbestos.

Occupational Exposure

Workers in multiple trades encountered Synkoloid ARTRA joint compound products on American jobsites during the period of documented asbestos use. According to asbestos litigation records, the trades most frequently identified in claims involving joint compound exposure include:

Drywall Finishers and Tapers — Professionals who applied joint compound as a primary job function faced the most sustained and direct exposure. Mixing dry compound from bags, applying multiple coats over seams, and sanding cured compound between coats generated repeated and concentrated airborne dust throughout the workday.

Painters — Painters frequently performed light sanding of joint compound to achieve acceptable surface profiles before priming and painting. Court filings document painters as a consistently identified occupational group in joint compound asbestos claims, often working in enclosed spaces with poor ventilation immediately after or alongside finishing trades.

Plasterers and Lathers — Workers in the plastering trades sometimes used finishing compounds interchangeably with or alongside traditional plaster products. The overlap between trade jurisdictions on residential and commercial projects placed these workers in proximity to joint compound dust.

Carpenters and Drywall Hangers — While the primary function of these workers was installation of drywall panels rather than finishing, they routinely worked in the same enclosed environments where compound was being mixed and applied. Bystander exposure in confined residential and commercial spaces is well-established in occupational health records.

HVAC Technicians and Electricians — Mechanical and electrical trades working in new construction regularly shared enclosed spaces — unventilated rooms, attic spaces, crawl spaces, and commercial floor plates — with finishing trades during the active application and sanding phases.

Homeowners and Do-It-Yourself Applicators — Joint compounds were marketed and sold through hardware and home improvement retailers for consumer use. Plaintiffs alleged that home renovators mixing and sanding these products without respiratory protection sustained exposures comparable to those of professional tradespeople, often in poorly ventilated residential settings.

The exposure hazard associated with joint compound sanding is specifically addressed in the asbestos-in-schools regulatory framework established under the Asbestos Hazard Emergency Response Act (AHERA), which identifies friable asbestos-containing materials — including cured and damaged joint compound — as requiring professional assessment and abatement. Regulatory guidance from the U.S. Environmental Protection Agency and the Occupational Safety and Health Administration has long identified drywall finishing dust as a category of occupational concern.

Court filings document that workers in the finishing trades historically received limited or no warnings about the asbestos content of joint compounds during the primary period of product use. Plaintiffs in litigation involving Synkoloid ARTRA products alleged that the absence of adequate hazard warnings and safety instructions on product packaging and data sheets contributed materially to ongoing and unprotected occupational exposure.

Mesothelioma, asbestosis, lung cancer, and other asbestos-related diseases carry latency periods typically ranging from ten to fifty years between initial fiber exposure and clinical diagnosis. This means that workers exposed to joint compound dust during the 1950s, 1960s, and 1970s may be receiving diagnoses today or in coming years. Family members who laundered work clothing contaminated with asbestos-bearing dust — a phenomenon documented in occupational medicine literature as para-occupational or household exposure — have also been identified as a population at risk.

Trust Fund / Legal Status

Synkoloid ARTRA is classified under Tier 2 for purposes of this reference, meaning the company has been named as a defendant in asbestos personal injury litigation but has not, to the knowledge of this reference site, established a Section 524(g) asbestos bankruptcy trust fund as of the time of publication.

According to asbestos litigation records, claims involving Synkoloid ARTRA products have proceeded through the civil court system. Individuals asserting injury from exposure to these products have pursued claims through traditional tort litigation rather than through an administrative trust fund claims process.

The absence of an established trust fund does not diminish the legal options available to individuals diagnosed with asbestos-related disease who can document exposure to Synkoloid ARTRA products. Civil litigation remains a viable avenue, and attorneys experienced in asbestos personal injury cases regularly evaluate claims involving Tier 2 manufacturers alongside claims against trust fund defendants, recognizing that most mesothelioma and asbestosis cases involve exposure to products from multiple manufacturers across a worker’s career.

If you or a family member has been diagnosed with mesothelioma, asbestosis, lung cancer, or another asbestos-related disease and has a work history involving joint compound products — including products manufactured by Synkoloid ARTRA — the following information is relevant to understanding your legal options:

  • Synkoloid ARTRA has been named in asbestos personal injury litigation. Claims involving these products have been brought through civil court proceedings.
  • No bankruptcy trust fund associated with Synkoloid ARTRA has been identified. Compensation claims are not handled through an administrative trust process but through litigation.
  • Documentation of exposure is critical to any claim. Work history records, union records, co-worker testimony, product identification through jobsite records or deposition testimony, and medical records establishing diagnosis are all potentially relevant.
  • Statutes of limitations apply to asbestos personal injury and wrongful death claims and vary by jurisdiction. Prompt consultation with an attorney experienced in asbestos litigation is strongly advised following diagnosis.
  • Multiple defendants are common. Most asbestos claims involve exposure to products from several manufacturers. An attorney will evaluate your full occupational history to identify all potentially responsible parties, including those with established trust funds that may provide compensation independent of any litigation outcome.

Workers and families seeking additional information about exposure history, product identification, or legal options should consult with an asbestos litigation attorney or contact established asbestos legal and medical resources for guidance specific to their circumstances.